The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

GLP-1s currently used for weight loss—although not all are expressly approved for this purpose—include Ozempic and Wegovy ...

Even so, this relatively lean state had among the nation’s biggest surges last year in residents taking blockbuster weight-loss drugs ... such as Wegovy and Zepbound in 2024, a 255 percent ...

Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...

Yeah, ouch. A new study found that men who took semaglutide (Wegovy) for weight loss were more likely to develop erectile dysfunction and low testosterone than those who didn’t. These drugs may ...

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Zepbound is the newest GLP-1 medication to be approved by the Food and Drug Administration (FDA) for weight loss. It’s available only by prescription for people with a body mass index (BMI ...